Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer

• Egile Nagusiak: Jeyachandran Dhanapriya (Egilea), Sankarakumar GaneshAravind (Egilea), Thanigachalam Dineshkumar (Egilea), Ramanathan Sakthirajan (Egilea), Balasubramaniyan T (Egilea), Natarajan Gopalakrishnan (Egilea)
• Formatua: Liburua
• Argitaratua: Archives of Clinical Nephrology - Peertechz Publications, 2017-03-27.
• Gaiak: Case Report
• Sarrera elektronikoa: Connect to this object online.

<p>Gemcitabine (2',2'-difl uorodeoxycytidine) is a potent pyrimidine antimetabolite and was introduced in 1987. It is commonly used for various tumors including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian can cer and renal cell carcinoma at advanced stages....